Citation: Rn. Brogden et al., AMPHOTERICIN-B COLLOIDAL DISPERSION - A REVIEW OF ITS USE AGAINST SYSTEMIC FUNGAL-INFECTIONS AND VISCERAL LEISHMANIASIS, Drugs, 56(3), 1998, pp. 365-383
Citation: W. Jeal et Kl. Goa, ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH RENAL-CELL-CARCINOMA (VOL 7, PG 285, 1997), Biodrugs, 8(3), 1997, pp. 192-192
Citation: S. Noble et Kl. Goa, ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH METASTATIC MELANOMA, Biodrugs, 7(5), 1997, pp. 394-422
Citation: W. Jeal et Kl. Goa, ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH RENAL-CELL CARCINOMA, Biodrugs, 7(4), 1997, pp. 285-317
Citation: Rh. Foster et Kl. Goa, PAROXETINE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF PANIC DISORDER, CNS DRUGS, 8(2), 1997, pp. 163-188
Citation: Kl. Goa et H. Lamb, DORNASE ALFA - A REVIEW OF PHARMACOECONOMIC AND QUALITY-OF-LIFE ASPECTS OF ITS USE IN CYSTIC-FIBROSIS, PharmacoEconomics, 12(3), 1997, pp. 409-422
Citation: Gl. Plosker et Kl. Goa, TERAZOSIN - A PHARMACOECONOMIC EVALUATION OF ITS USE IN BENIGN PROSTATIC HYPERPLASIA, PharmacoEconomics, 11(2), 1997, pp. 184-201
Citation: Kl. Goa et al., SIMVASTATIN - A REAPPRAISAL OF ITS COST-EFFECTIVENESS IN DYSLIPIDEMIAAND CORONARY HEART-DISEASE, PharmacoEconomics, 11(1), 1997, pp. 89-114
Citation: Cm. Spencer et al., TACROLIMUS - AN UPDATE OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN THE MANAGEMENT OF ORGAN-TRANSPLANTATION, Drugs, 54(6), 1997, pp. 925-975
Citation: S. Noble et Kl. Goa, GEMCITABINE - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL POTENTIAL IN NONSMALL CELL LUNG-CANCER AND PANCREATIC-CANCER, Drugs, 54(3), 1997, pp. 447-472